LINZ GUENTER has a total of 13 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are OXFORD DRUG DESIGN LTD, BACON EDWARD R and BERGNES GUSTAVE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Linz Guenter | 13 |
#2 | Kraemer Gerd | 7 |
#3 | Schmid Rolf | 5 |
#4 | Sieger Peter | 5 |
#5 | Rall Werner | 2 |
#6 | Gutschera Ludwig | 2 |
#7 | Asche Geert | 2 |
#8 | Grauert Matthias | 2 |
#9 | Leuter Zeno A | 1 |
#10 | Kraemer Gerd F | 1 |
Publication | Filing date | Title |
---|---|---|
US2011190499A1 | Selective synthesis of functionalized pyrimidines | |
US2008076934A1 | (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |